 |
| September
17, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
|
BIG4BIO
CEO WEEKLY Q&A:
Dr. Manish Arora, Founder and CEO,
LinusBio |
| In
this CEO Q&A, Dr. Arora explains the
insight that launched LinusBio, what sets
the company’s hair-based platform apart
from other diagnostic approaches, the
milestones and challenges shaping its
growth from academic research to
commercial product, and where he sees
exposome science heading. More |
|
|
- Alloy Therapeutics: Selected to Join the
World Economic Forum’s Unicorns Community More
- Charles River: Leverages Expertise in Rapid
and In Vitro Methods to Reduce Cell Banking
Timelines More
- Ginkgo Datapoints: Partnership With TuneLab
to Close the Gap Between AI Models and Lab
Data More
- X-Chem: Named First Winner of Chordoma
Foundation TBXT Challenge With Discovery of
Novel Binder for Untreatable Bone Cancer
Target More
|
|
 |
CRCFO
Advisory
Reassessing your business plan?
We provide financial leadership.
Smart. Nimble. Flexible. |
|
Learn More
→ |
|
|
- Biotech Movers September 16, 2026: Tempest
TPST +59% on In Vivo CAR-T Deal; Xenetic XBIO
-49% on Santersus Merger More
- Emergent BioSolutions Restarts
Massachusetts Manufacturing After $34.5M
Vaccine Deal More*
- More on Micro Cap Xenetic Biosciences
Expanding Therapeutic Platform With Santersus
Acquisition More
- More on Novartis Paying Sironax $125M to
Acquire Platform for Crossing the Blood-Brain
Barrier More
- More on Sensorion Filing Confidentially for
Potential U.S. IPO More
- Quanterix: Inducement Grants Under Nasdaq
Listing Rule 5635(c)(4) More
- Stoke Therapeutics: Inducement Grants Under
Nasdaq Listing Rule 5635(C)(4) More
- Work Begins on $56 Million Buildout for
Transmedics in Somerville More*
|
|
|
 |
Pace®
Life Sciences
The CDMO That Takes You Further.
Your partner for Product
Development, Manufacturing,
Analytical Testing, Regulatory
Consulting & Operational
Support. |
|
Learn More
→ |
|
|
- Big4Bio CEO Weekly Q&A: Dr.
Manish Arora, Founder and CEO, LinusBio More
- Biotech & Pharma Updates | September 16,
2026
More
- Charles River Celebrates Thirty
Years of Biotech Innovation More
- More on Skyhawk Racking Up More Support for
Huntington’s Drug
More
- Prime Assembly Expands Genome Editing With
Precise, Large-Scale DNA Integration More
- Subscribe to LifeSci Startup for
Updates on US Startups More
- When Drug Development Becomes
Personal: Meg Gill’s Mission to Find a
Treatment for Her Daughter More
- Wyss Institute: Building Big With DNA
Gets a Software Upgrade More
|
|
- AI is Changing the Talent Biotech Companies
Compete to Hire More
- Avalyn: Appoints Robert J. Meyer, MD, to Its
Board of Directors More
- OPPORTUNITY: Chief Financial Officer,
Boston/San Diego More
- OPPORTUNITY: SVP, Regulatory and Quality
Assurance, Boston/San Diego More
- OPPORTUNITY: Head of Global Research &
Development, Columbia, MD More
- PhaseV: Appoints Biopharma Leaders Klaus
Beck and Avi Kulkarni to Scientific Advisory
Board to Guide Expansion of AI Conductor More
- Ratio Therapeutics: Appointment of Kenan
Turnacioglu to Its Board of Directors More
- Slone Partners: Behind the Search’ -
A Conversation with George Quinn, Partner,
Fractional Talent More
- Slone Partners: ICYMI - How to Keep Your
Highest Performers Engaged More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Boston Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Boston,
all rights reserved 2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
